A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...

Columnist Desiree Lama remembers how a best friend helped her with stressful assignments and RRMS symptoms in college.

MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide ...

“These findings reaffirm that the current Ocrevus IV 600 mg is optimally dosed to significantly slow disability progression,” ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

It took a decade for Heather Castellani Milboer to be diagnosed with multiple sclerosis. Now, she helps build community for ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...

March is regonized as multiple sclerosis awareness month. One woman is shining a light on MS and sharing a message of hope ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial ...